References
- PalellaFJDelaneyKMMoormanACDeclining morbidity and mortality among patients with advanced human immunodeficiency virus infectionN Engl J Med1998338138538609516219
- DimalaCABlencoweHAssociation between highly active antiretroviral therapy and selected cardiovascular disease risk factors in sub-Saharan Africa: a systematic review and meta-analysis protocolBMJ Open201773e013353
- PaulaAAFalcãoMCPachecoAGMetabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspectsAIDS Res Ther20131013224330597
- BonjochAFiguerasMEstanyCHigh prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort studyAIDS201024182827283321045635
- MasyeniSUtamaSSomiaAWidianaRMeratiTPFactors influencing bone mineral density in ARV-naive patients at Sanglah Hospital, BaliActa Med Indones201345317517924045386
- Kementerian Kesehatan Republik IndonesiaPedoman pengobatan antiretroviral. Peratur Meteri Kesehat Republik Indones Nomor 87 Tahun 201420141121
- CarrAHIV lipodystrophy: risk factors, pathogenesis, diagnosis and managementAIDS200317Suppl 1S141S14812870540
- Friis-MøllerNReissPSabinCAClass of antiretroviral drugs and the risk of myocardial infarctionN Engl J Med2007356171723173517460226
- BolhaarMGKarstaedtASA high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South AfricaClin Infect Dis200745225426017578788
- HernàndezSMorénCLópezMPerinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newbornAIDS201226441942822156962
- JohnMMooreCBJamesIRChronic hyperlactatemia in HIV-infected patients taking antiretroviral therapyAIDS200115671772311371686
- MontanerJSGCôtéHCFHarrisMNucleoside-related mitochondrial toxicity among HIV-infected patients receiving antiretroviral therapy: insights from the evaluation of venous lactic acid and peripheral blood mitochondrial DNAClin Infect Dis200438Suppl 2S73S7914986278
- NogueraAFortunyCMuñoz-AlmagroCHyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretroviralsPediatrics20041145e598e60315492359
- CasulaMVrisekoopNWitFWMitochondrial DNA decline in T cells of HIV-1 seroconverters may be dependent on immune activationJ Infect Dis2007196337137617597451
- MorseCGVossJGRakocevicGHIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissueJ Infect Dis2012205121778178722476717
- MenshawyAIsmailAAbushoukAIEfficacy and safety of atazanavir/ritonavir-based antiretroviral therapy for HIV-1 infected subjects: a systematic review and meta-analysisArch Virol201716282181219028361290
- StolbachAPazianaKHeverlingHPhamPA review of the toxicity of HIV medications II: interactions with drugs and complementary and alternative medicine productsJ Med Toxicol201511332634126036354
- MontessoriVPressNHarrisMAkagiLMontanerJSGAdverse effects of antiretroviral therapy for HIV infectionCMAJ2004170222923814734438
- McComseyGAO’RiordanMAChoiJMitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovirAntivir Ther201217234735322293126
- SarnatHBMarín-GarcíaJPathology of mitochondrial encephalomyopathiesCan J Neurol Sci200532215216616018150
- WalkerUABickelMLütke VolksbeckSIEvidence of nucleoside analogue reverse transcriptase inhibitor – associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patientsJ Acquir Immune Defic Syndr200229211712111832679
- CôtéHCFBrummeZLCraibKJPChanges in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patientsN Engl J Med20023461181182011893792
- JitratkosolMHJSatthaBMaanEJBlood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancyAIDS201226667568322436539
- SetzerBSchlesierMThomasAKWalkerUAMitochondrial toxicity of nucleoside analogues in primary human lymphocytesAntivir Ther200510232733415865227
- TaylorSWakemMDijkmanGAlsarrajMNguyenMA practical approach to RT-qPCR – publishing data that conform to the MIQE guidelinesMethods2010504S1S520215014
- KimMJJardelCBarthélémyCMitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophyAntimicrob Agents Chemother20085251670167618332166
- GingelmaierAGrubertTAKostBPMitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapyAntivir Ther200914333133819474467
- HernándezSCatalán-GarcíaMMorénCPlacental mitochondrial toxicity, oxidative stress, apoptosis, and adverse perinatal outcomes in HIV pregnancies under antiretroviral treatment containing zidovudineJ Acquir Immune Defic Syndr2017754e113e11928234688
- AkaikeTMaedaHNitric oxide and virus infectionImmunology2000101330030811106932
- WhiteAJMitochondrial toxicity and HIV therapySex Transm Infect200177315817311402222
- JacototEFerriKFEl HamelCControl of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2J Exp Med2001193450951911181702
- CasulaMBosboom-DobbelaerISmoldersKInfection with HIV-1 induces a decrease in mtDNA2005191914681471
- MaagaardAHolberg-PetersenMKollbergGOldforsASandvikLBrunnJNMitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patientsAntivir Ther200611560160816964828